Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

Metastatic spinal cord compression
Tackling the burden of avoidable deaths due to late presentation of cancer Amanda Ramirez On behalf of KCL Promoting Early Presentation Group.
One-stop dyspepsia clinic
Early Diagnosis and Primary Care
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Living well with dementia: more timely diagnosis and early intervention Louise Robinson Professor of Primary Care and Ageing RCGP National Clinical Champion.
Detecting Cancer earlier in Tower Hamlets – The New Network Service Dr. Tania Anastasiadis Tower Hamlets GP Cancer Lead & GP Macmillan facilitator The.
Shaping a blueprint for cancer Plymouth Cancer Summit Sean Duffy February 2015.
Improving Cancer Outcomes at a national level - The story from England Professor Sir Mike Richards National Cancer Director June
Practice Profiles #ICATraining Improving Cancer Awareness Train the GP Trainers.
Dermatology Clinical Assessment and Treatment Service: NW Hertfordshire (St Albans, Harpenden and Hertsmere) Dr. Simon Dawe Consultant Dermatologist.
Nicola Barnstaple Programme Manager. Key challenges in Scotland Increasing cancer incidence – predicted 35,000 cases per year in 2020 Ageing population.
Optimising symptomatic cancer diagnosis in primary care Dr Fiona Walter The Primary Care Unit Cambridge Institute AWAY DAY 25 th June 2014 of Public Health.
Oesophageal Cancer. -improving outcomes. Anil Kaul Consultant General and Upper GI Surgery St Helens and Knowsley Teaching Hospitals NHS Trust.
School for Primary Care Research Increasing the evidence base for primary care practice The School for Primary Care Research is a partnership between the.
How is place of death for cancer patients changing and what affects it? UKACR Conference September 28 th 2004 Elizabeth Davies Karen Linklater Ruth Jack.
Ian Arnott Consultant Gastroenterologist Western General Hospital Edinburgh The Use of Faecal Calprotectin in Primary Care.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Early Cancer Diagnosis in Primary Care: The evolving evidence Thomas Round GP XX Place Tower Hamlets Academic Clinical Fellow KCL
Achieving improved cancer outcomes- a pathway approach, engaging primary care and partners Kathy Elliott Programme Director – NHS Improving Quality (Delivery.
Cancer care commissioning priorities – South East London Summary of discussions from meeting held: Tuesday 10 th July, 6pm-8pm at Guy’s Hospital.
Risk of skin cancer following phototherapy for neonatal jaundice: retrospective cohort study David H Brewster, 1,2 Janet S Tucker, 3,4 Michael Fleming,
Clare Rogers Consultant Breast Surgeon Doncaster and Bassetlaw Hospitals.
Detect Cancer Early. February 2012 The Scottish Government Announced
Department of General Practice Aarhus University Diagnostic delay in cancer in primary health care Before and after introducing urgent referrals for suspected.
Increasing awareness and early diagnosis of cancer An update from Primary Care Jo Preston Service Improvement Facilitator NECN Dr Bill Hall Primary Care.
Greg Rubin Professor of General Practice and Primary Care University of Durham.
National Perspective Cancer Early Detection & Prevention Performance Review Event October 2008 National Cancer Action Team Kathy Elliott National Lead.
Socio-economic inequalities in the pathway of care for pancreatic cancer James Brown, Jean Adams, Martin White & Mark Pearce Institute of Health & Society.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
MARK COLEMAN MBChB FRCS (Gen Surg) MD hon FRCPSG Consultant Colorectal Surgeon
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
Evaluating Screening Programs Dr. Jørn Olsen Epi 200B January 19, 2010.
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Acute Oncology Service (AOS) Monday – Friday 8am – 4pm Bleep: 946 T: x5726 F: Dr Nicola Beech Dr Jillian Noble Dr Susannah.
Endoscopy Matters NICE guidance dyspepsia, New build, National Context & NAEDI Dr Michelle Gallagher Consultant Gastroenterologist.
Improving Cancer Outcomes in Camden Dr Lucia Grun 15 October 2014.
Dr Jaimin Patel Macmillan GP- Croydon
Rachel Rowlands 17 th May  2012 Be Clear on Cancer campaign  Aims of the study  Methodology  Results  Conclusions  Limitations  Recommendations.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
Two-week wait referrals for malignant melanoma: A clinical audit carried out across four UK Cancer Networks South West Cancer Intelligence Service
Breast cancer in NE London Frances Haste, Public Health lead.
Routes to Diagnosis of Cancer in London, Katherine Henson, NCRAS, Presentation for London Public Health Knowledge and Intelligence Network.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
What does the cancer intelligence landscape look like now? Dr Mick Peake Clinical Lead, National Cancer Intelligence Network.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
+ Using QCancer in EMIS Web Julia Hippisley-Cox, Professor General Practice, Director QResearch, Director ClinRisk Ltd. EMIS National User Group 2015 Nottingham.
South West Public Health Observatory South West Regional Public Health Group How will the new National End of Life Intelligence Network support commissioning.
Variation in place of death from cancer: studies in South East England Elizabeth Davies, Peter Madden, Victoria Coupland, Karen Linklater, Henrik Møller.
[NAME CCG] [DATE] [FACILITATOR] Early Diagnosis of Cancer Quality Improvement using Cancer Significant Event Analysis [CCG MAP]
Diagnostic Intervals in Breast, Colorectal, Lung, Pancreatic, Oesophageal and Gastric Cancers and : Database Study Richard D NealBangor.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
West Yorkshire R & D Cancer and palliative care workshop
Cancer Audit Stourport Health Centre Feb 2016
Greg Rubin,1 Nafees Din,2 Richard Neal,2 William Hamilton3
Prepared by staff in Prevention and Cancer Control.
Jane E Scullion Respiratory Nurse Consultant
Dr James Carlton, Medical Adviser
HEALTH PROFESSIONAL ENGAGEMENT PROGRAMME:
National Cancer Diagnosis Audit
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Dr Constantinos Koshiaris
Variation in use of the 2-week referral pathway for suspected cancer: A cross-sectional analysis by David Meechan, Carolynn Gildea, Louise Hollingworth,
Guidelines and Standards in Lung Cancer
Faecal Immunochemistry Test - qFIT
Presentation transcript:

Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health England, Knowledge & Intelligence (CG, DM, HM) Durham University (GR) Primary Care and Public Health Sciences, KCL (TR) Cancer Diagnosis in Primary Care, Aarhus University (HM, PV) Association between use of the English urgent referral pathway for suspected cancer and mortality outcome in cancer patients: cohort study

>1 in 2 people in the UK with develop cancer (Ahmad 2015) >300,000 patients are diagnosed and >150,000 die every year from cancer in the UK (CRUK) Late diagnosis is a major contributing factor to relatively poorer cancer survival rates in the UK (Richards 2009) >10,000 premature cancer deaths per year could be avoided if survival rates matched the best in Europe ( Abdel- Rahman 2007) Nearly 1 in 4 patients diagnosed via an emergency admission route with poorer 1 year survival (Elliss Brookes 2012) Cancer in the UK

Colorectal Cancer 1yr RS Lung Cancer 1yr RS Breast Cancer 1yr RSOvarian Cancer 1yr RS ICBP: 1 year relative survival Coleman et al, Lancet 2011

Delays in Symptomatic Cancer Diagnosis Model of Total Patient Delay (Walter 2012)

Cancer: National Awareness and Early Diagnosis Initiative (NAEDI) (Hiom 2015)

Most of those with cancer present with symptoms, and most of these presentations are to primary care (Rubin 2011) Suspecting a diagnosis of cancer in general practice is not straightforward: average full time GP 7-8 new cancer cases/year (Richards 2009) Low predictive value of even “red flag” symptoms eg PPV rectal bleeding 2.4% (Jones 2007) Many patients have multiple GP visits prior to referral especially those with cancers of greater diagnostic difficulty (Lyratzopoulos 2014) Primary Care and Cancer

Three or more general practitioner consultations before hospital referral (Lyratzopoulos 2012)

Referral guidelines for suspected cancer, DoH 2000 Referral guidelines for suspected cancer, NICE 2005 ”Urgent referral” (Two week wait/2ww) The patient is seen by a specialist within 14 days, and The patient is treated within 62 days from referral or within 31 days from the decision to treat Updated NICE referral guidance due for publication May 2015 Referral for suspected cancer

Change in diagnostic intervals 2001/02 – 2007/08 (Neal 2013)

The “waiting time paradox” (Torring 2011)

Urgent Referrals

Variation in a care process Variation in a relevant outcome ? Use of the urgent referral pathway and mortality outcome in cancer patients

Histogram of referral ratio Referral ratio

Histogram of conversion rate Conversion rate

Histogram of detection rate Detection rate

Strategy of analysis Mortality of urgently referred cancer patients Mortality of other cancer patients ? =

Strategy of analysis Mortality of urgently referred cancer patients Mortality of other cancer patients Mortality of cancer patients from GP practices with high use of urgent referral ? Mortality of cancer patients from GP practices with low use of urgent referral = ? =

r: 0.42 Data: England; 2009; 215,284 cancer patients from 8049 GP practices

Cohort analysis of death rates, adjusted for age, sex and cancer type Cox proportional hazards regression Sensitivity analyses Analysis

Analysis by tertiles of distributions

Analysis by deciles of distributions

A. Hazard ratio for death, by decile of referral ratio.

B. Hazard ratio for death, by decile of conversion rate.

C. Hazard ratio for death, by decile of detection rate.

Joint effects of referral ratio, conversion rate and detection rate

High use of urgent referral Underlying mechanisms? Low mortality; (High survival)

High use of urgent referral Short delay; Earlier stage; Treatment options Low mortality; (High survival) Underlying mechanisms?

High use of urgent referral Short delay; Earlier stage; Treatment options Low mortality; (High survival) GP’s awareness of cancer ? Underlying mechanisms?

High use of urgent referral Short delay; Earlier stage; Treatment options Low mortality; (High survival) GP’s awareness of cancer ? Underlying mechanisms?

The analysis suggests that urgent referral for suspected cancer is efficacious. The roles of a direct mechanism (via reduced delay) and indirect mechanisms (via awareness) are not known. GP practices with consistent low use of urgent referral may benefit their cancer patients from using it more often, and from being more aware of signs of cancer. Conclusions and implications

r: 0.42

Referral ratio Detection rate r: 0.42

27% of patients: 1.07 ( ) 57% of patients % of patients 0.95 ( )